Psyence Biomedical Completes Investment in PsyLabs Following Milestone Achievement
Psyence Biomedical Ltd. has finalized a $2,599,896 investment in Psyence Labs Ltd. after achieving key regulatory and manufacturing milestones for its ibogaine program.